Backed by 25
Years of Science
and Research

Group 1171277513

What are stem cells?

Stem cells are specialized cells with the ability to support the body’s natural repair and signaling processes. In regenerative medicine, mesenchymal stem cells (MSCs) are widely studied for their role in cellular communication, immune modulation, and tissue support.

Scientific and clinical research continues to explore how MSCs interact with surrounding cells through signaling pathways, growth factors, and extracellular vesicles.

Scientific and Clinical Studies

  • Scientific Presentations
  • Our Patient-Reported Outcomes
  • Published Research
Group 1171277503

At Zigna Genix,

Wharton’s Jelly–Derived
Mesenchymal Stem Cells

At ZignaGenix, we work with Wharton’s Jelly–derived mesenchymal stem cells (WJ-MSCs), including our proprietary Infinity Hypoxic Live Stem Cells™, cultivated under controlled laboratory conditions.

These cells are selected and prepared with careful attention to sourcing, handling, and growth practices to support consistency and cellular integrity throughout the preparation process.

Allogeneic Therapies

Allogeneic MSCs are derived from screened donors and prepared for use without requiring a patient’s own cells. This approach allows for standardized preparation methods and consistent quality controls across batches.

All protocols are designed with patient safety, regulatory awareness, and responsible laboratory practices in mind.

Screening

Although donors are screened for health issues, the cells extracted from umbilical cords are then tested for specific proteins and genes that research has identified offer high potential for effective treatment.

Purification

Cells that pass screening tests are purified and expanded so that therapy can be prepared that contains millions of high-potency cells that the body can use to promote healing, modulate the immune system, and reduce inflammation.

Ongoing Testing

Cells are tested as they are expanded and “passaged” into larger containers. Once expansion is complete, cells are tested again to verify that they meet various markers and criteria for purity and potency.

Cryo-Preservation

After cells have been expanded and tested, they are frozen in our cell bank. When reactivated, they are tested once more to ensure quality and viability.

Three mechanisms of how these cells can work are:

  • Anti-inflammatory and angiogenesis through paracrine activity
  • Stabilize and repair damaged native cells through mitochondrial transfer and growth factors
  • Regenerate new tissue through exosome secretion to signal the body’s response to damage.

What are the benefits

How MSCs Support Cellular
Communication

Rather than replacing damaged tissue directly, MSCs are studied for how they communicate with surrounding cells. This includes signaling that may support immune balance, inflammation response, and tissue environment regulation.

Research continues to examine how these cellular interactions may contribute to broader regenerative processes.

What Defines a
High-Quality MSC Profile?

Cell quality depends on how cells are grown, handled, and maintained — not just where they come from.

High-quality MSCs are characterized by:

These factors help preserve cell integrity, signaling behavior, and consistency.

image (1)

Early Passage Cells (P1–P3)

Passage refers to how many times cells are transferred during growth. Early passage cells are handled fewer times, helping preserve their original structure and behavior.

Preferred range:

Limiting passages helps maintain the cells’ original structure and behavior.

Biologically Younger Cells

Generation refers to how many times a cell has divided during growth.

Even at the same passage level, cells can differ in biological age depending on how aggressively they were expanded.

Line 15
Line 15

Balanced Growth
Over Volume

Our Protocols to Precisely Target
Treatment Areas

Expansion increases cell quantity to usable levels while maintaining cellular stability. Responsible expansion avoids unnecessary stress and prioritizes consistency over volume.

Ellipse 2901 (1)

Adequate cell
yield without over-forcing growth

Ellipse 2901 (1)

Avoiding unnecessary cellular stress

Ellipse 2901 (1)

Preserving natural cell behavior

Group 1171277821 (1)

Responsible expansion prioritizes

Our Cell Quality Philosophy

Early passage + low generation + controlled expansion

Rather than prioritizing speed or volume, our protocols emphasize controlled growth and respect for cellular biology throughout the process.

This philosophy helps differentiate responsible cell preparation from volume-driven claims often seen elsewhere.

Group 1171277537 (4)
Group 1171277813_upscayl_14x_upscayl-standard-4x 1

Patient-Centered Care Model

Our process is designed to ensure patients speak with trained professionals at the appropriate stage of their journey. This allows for focused consultations, clear communication, and a more streamlined experience from inquiry to care coordination.

Group 1171277821 (3)

treatment Protocols

• Zigna Genix Treatment Protocols

• Degenerative Disc Disease

• Knee Osteoarthritis

• Shoulder & Elbow Overuse Injuries

• Spinal Cord Injuries

• Tendinopathies

• Erectile Dysfunction

Clinical Care Program

• Regular follow-up: patients not included in research protocols

• Research follow-up; patients included in search protocols

• Specific follow-up period for each protocol

• Patient educational interventions

Case Studies and
Case Reports

Observational
Research Protocols

• Zigna Genix Treatment Protocols

• Degenerative Disc Disease

• Knee Osteoarthritis

• Shoulder & Elbow Overuse Injuries

• Spinal Cord Injuries

• Tendinopathies

• Erectile Dysfunction

Clinical Trials

• COVID 19

• Spinal Cord Injury

• Concussion

Preclinical Research Unit

Design and assembly of laboratory experiments and tests, original articles, reviews, and short articles

Data Analytics

Information analysis for knowledge generation, management reports for decision-making and other institutional reports, infographics, and other marketing materials

Clinical Research Unit

Clinical trials, observational research, protocols, case series, and case reports

Evidence Synthesis

Systematic literature reviews, evidence synthesis for clinical management decision making, creation, adoption, and adaptation of clinical practice guidelines, and management guidelines by consensus of experts

Research and Innovation

BioXscience, a subsidiary of Zigna Genix, is responsible for planning and executing our research and innovation activities aimed at identifying specific knowledge gaps in the field of regenerative medicine.

Our Methodology

The BioXscience team develops and publishes meta-analyses and systematic reviews to combine peer-reviewed literature, case studies, and observational data in the creation of best practice, patient-specific protocols that include MSC therapy with complementary therapies. Together, optimal patient outcomes are achieved with improvements in pain, function, and quality of life.

Guided by Research
and Best Practices

Our care protocols are informed by existing scientific literature and commonly accepted laboratory practices, with an emphasis on responsible application and continuous evaluation.

Our approach to healthcare is distinguished by evidence-based care protocols meticulously designed to address various medical conditions.

  • Dermatological conditions
  • Orthopedic/musculoskeletal disorders
  • Degenerative disc and spine disorders
  • Neurological disorders
  • Rheumatologic and autoimmune diseases
  • and other medical conditions
Group 1171277572

Ongoing Scientific
Collaboration

ZignaGenix continues to explore educational initiatives, scientific publications, and collaborative research efforts to contribute to broader understanding in regenerative medicine.

• Development of the highest potency Wharton’s jelly umbilical cord MSCs
• The use of highly concentrated exosomes to complement MSC therapy
• Internationally recognized research publications and presentations
• 97% patient satisfaction after post-treatment survey
• Published patient-reported outcomes

References

Dermatological Conditions​
Dermatological Conditions​

Find all the tools you’ll need to create advanced websites in one place. Stop waisting time searching for solutions.

Dermatological Conditions​
Dermatological Conditions​

Find all the tools you’ll need to create advanced websites in one place. Stop waisting time searching for solutions.

Dermatological Conditions​
Dermatological Conditions​

Find all the tools you’ll need to create advanced websites in one place. Stop waisting time searching for solutions.

Dermatological Conditions​
Dermatological Conditions​

Find all the tools you’ll need to create advanced websites in one place. Stop waisting time searching for solutions.

Dermatological Conditions​
Dermatological Conditions​

Find all the tools you’ll need to create advanced websites in one place. Stop waisting time searching for solutions.

zignagenix_logo 1 (1)

Take Advantage of Advanced Treatments With
the Potential to Support Your Wellness Journey